17 hours ago
Johnson & Johnson rolls out TECNIS Odyssey IOL in selected regions
Johnson & Johnson (J&J) has introduced the TECNIS Odyssey IOL in the Middle East, Canada, and Europe, expanding its range of presbyopia-correcting intraocular lenses (PC-IOLs).
This new lens is designed to provide patients with quality, continuous vision across all distances, significantly reducing the dependency on glasses.
The TECNIS Odyssey IOL is built upon the TECNIS platform, which combines optics and materials to deliver clear, high-contrast vision.
According to the company, it is designed to enhance visual freedom for patients, providing accurate vision for activities ranging from reading to driving.
Individuals who have received the IOL reported they are satisfied with their overall vision without glasses.
The IOL's freeform diffractive surface is engineered to provide seamless vision at near, intermediate, and far distances, with 96% of people satisfied with their ability to read on tablets or smartphones, and 97% with their distance vision.
Additionally, the TECNIS Odyssey IOL is designed to reduce night vision disturbances such as glare and halos, offering improved image quality than PanOptix both day and night.
It was observed that 92% of individuals expressed satisfaction with their ability to see steps and read street signs at night.
The company's portfolio in the Middle East, Europe, Japan and Canada now includes both the TECNIS Odyssey IOL and the TECNIS PureSee IOL.
While the TECNIS Odyssey is also available in Japan, the US, and Puerto Rico, the TECNIS PureSee is offered across Latin America and Asia-Pacific but has not yet received PMA approval in the US.
J&J Vision Company Group chairman Peter Menziuso said: 'TECNIS Odyssey IOL is the fastest growing PC-IOL in the US, and we are excited to be making it available to more patients around the world. It addresses a significant unmet need for cataract patients seeking greater spectacle independence.'
In recent news, J&J MedTech introduced the ETHICON 4000 Stapler, a surgical device designed to manage tissue complexities and ensure staple line integrity during surgeries.
"Johnson & Johnson rolls out TECNIS Odyssey IOL in selected regions" was originally created and published by Medical Device Network, a GlobalData owned brand.
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
